The extracorporeal membrane oxygenation (ECMO) machine market is poised to reach USD 305.3 Million by 2028 at a CAGR of 4.3% during the forecast period of 2019 to 2028.  One of the key factors driving this market is the rising incidence of cardiopulmonary disease and respiratory failure. According to the Centers for Disease Control and Prevention (CDC), an individual dies every 37 seconds from cardiovascular disease in the U.S. Furthermore, chronic obstructive pulmonary disease (COPD) was among the leading causes of death in the U.S in 2019.

Top Driver: Increasing number of hospitals offering extracorporeal membrane oxygenation (ECMO) machine services

The increasing number of hospitals offering extracorporeal membrane oxygenation (ECMO) machine services and a rising number of awareness programs are some of the other factors boosting the market growth. According to the Federal Agency of Health Research and Quality, 6,890 extracorporeal membrane oxygenation procedures were performed in the U.S in 2014. Thereafter, the adoption of ECMO machines in hospitals has increased significantly. According to the Extracorporeal Life Support Organization, the number of hospitals offering ECMO services reached 264 in 2019, up from 108 in 2008.

Increasing awareness about extracorporeal membrane oxygenation procedures and ongoing technological advancements are further propelling the market. Many government organizations are working to spread awareness about these procedures across the globe. Initiatives such as the Global Initiative for Chronic Obstructive Lung Disease (GOLD) aims at creating awareness about COPD and its treatment, which includes the usage of ECMO devices. Furthermore, the increasing adoption rate of extracorporeal membrane oxygenation machines is catalyzing technological advancements in these systems. The latest advancement includes oxygenators, hollow pumps, and heparin coated cannula used for various application in surgeries. In addition, recently developed ECMO machines are smaller in size, thus increasing their portability and applications. Portable adaptors and compact extracorporeal membrane oxygenation machine circuits have also been developed, which helps in the transportation of critically ill patients.

Adult patients segment to Make Crucial Contribution to Growth of Global extracorporeal membrane oxygenation (ECMO) machine Market

Patient Type,Based on patient type, the extracorporeal membrane oxygenation machine market is segmented into neonates, pediatric, and adult. The adult patients segment accounted for the largest market share in 2019 and is also expected to grow at the fastest rate during the forecast period. Soaring consumption of alcohol, tobacco, and smoking, coupled with a widespread sedentary lifestyle, is increasing the global burden of cardiac and respiratory diseases in adults. According to a report published by the Extracorporeal Life Support Organization, in January 2016, there were around 7,850 adults suffering from cardiac illnesses that required ECMO.The pediatric patient segment also accounted for a considerable share in the extracorporeal membrane oxygenation machine market in 2019 and is expected to grow at a robust pace over the course of the forecast period. One of the key factors driving this segment is an increase in the number of children with various pulmonary heart diseases. According to the Extracorporeal Life Support Organization, in January 2016, around 8,102 children suffered from cardiac illnesses and required ECMO therapy.

ECMO Machine Modality ,Veno-venous ECMO market is anticipated to grow considerably during the forecast period to reach USD 136.5 million by 2025. Availability of cannulas such as Avalon ELITE and Protek Duo in the market that use the internal jugular approach during ECMO procedure will drive the device adoption rate over the coming years. The benefits associated with these devices include reduced risk of bleeding, ease of mobilization and lower rate of recirculation driving the Veno-venous extracorporeal membrane oxygenation market. Additionally, increasing incidence of severe acute respiratory failure will further drive the business growth.

Veno-arterial (VA) ECMO segment is projected to be the fastest growing segment accounting for over 45% market share in 2018. Increasing incidence of cardiac disorders will act as major impact rendering factor for the growth of veno-arterial ECMO market. VA-ECMO offers enhanced hemodynamic support to patients suffering from severe conditions including cardiogenic shock. It is also used in providing periprocedural support to the acute heart failure patients. Thus, growing application of veno-arterial (VA) ECMO in treating cardiovascular conditions will stimulate the business growth over the projected timeframe.

Rising presence of major players and frequent product launches to Benefit North America Market

Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America is leading the global market for extracorporeal membrane oxygenation machines owing to the presence of major players and frequent product launches. The growth of this market can also be attributed to government support for quality healthcare, high purchasing power parity of patients, and increasing prevalence of diseases such as chronic obstructive pulmonary disease (COPD) in the U.S. and Canada. The presence of sophisticated healthcare facilities and favorable reimbursement policies have led to increased hospital admission rates, which in turn is expected to boost the usage rate of ECMO machines in the region.

The Asia Pacific market for extracorporeal membrane oxygenation machines is expected to witness the fastest growth during the forecast period. One of the key factors driving this market is the increase in healthcare expenditure by government and private agencies in order to improve healthcare facilities. Economic development in countries such as Japan, India, and China, coupled with rising government initiatives related to the development of healthcare infrastructure and reimbursement policies, is further expected to augment ECMO machines market.

Players to Focus on Expanding Applications in Global extracorporeal membrane oxygenation (ECMO) machine Market

The major players covered in the report are Getinge AB, Medtronic, Terumo Cardiovascular Systems Corporation, MicroPort Scientific Corporation, Fresenius Medical Care AG & Co. KGaA, NIPRO, LivaNova PLC, OriGen Biomedical, ALung Technologies, Inc., Abbott, EUROSETS, Braile Biomédica, Elsius Biomedical among other players domestic and global. Market Share data is available for Global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separatelyIn May 2018, EOLIA trial results indicated that patients subjected to appropriate ventilation management strategy along with early ECMO showed reduced mortality rate among patients suffering from severe acute respiratory distress syndrome (ARDS). Maquet Cardiopulmonary GmbH provided devices required for the EOLIA trial.

In September 2017, CytoSorbents Corporation launched the CytoSorb Therapeutic ECMO kit in Austria. The kit combines CytoSorb blood purification cartridge with innovative tubing connector set that allows easy integration in most of the commercial ECMO systems available in the market.

Scope of the Report

By ECMO Machine Component Type

• Pumps
• Oxygenator
• Controllers
• Cannula
• Accessories

By ECMO Machine Modality

• Veno-arterial
• Veno-venous
• Arterio-venous

By Region

• North America
• Europe
• Asia Pacific
• SAMEA

Key Reasons to Purchase this Report 

1. It provides a technological development map over time to understand the growth rate of the industry.

2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.

3. It renders definite analysis for changing competitive dynamics.

4. It builds a seven-year estimate based on how the market is predicted to grow.